retatrutide trial weight loss results Retatrutide, a new drug not available on the market yet, is showing promising in trials. @DrLaPook explains it’s doing much more than what current medications can Retatrutide Delivers Bariatric-Level Weight Loss

For more snack ideas that fit the bill, check out our High-Protein Snacks collection

Regulatory Context Research Procurement Status Retatrutide is an investigational new drug not approved by the FDA for human use

A separate systematic review of 26 RCTs involving 15,491 participants found placebo-adjusted weight loss of approximately 22% for retatrutide 12mg, 18% for tirzepatide 15mg, and 14% for semaglutide 2.4mg, an effect-size hierarchy consistent across analyses

doi: 10.1080/10408398.2021.1986465 129

In #WeAreNotWaiting diabetes DIY groups online, you can regularly find instances where people have donated old transmitters and sensors to fellow experimenters to reuse for testing and building purposes